UZH-Logo

Maintenance Infos

Safety of contrast-enhanced ultrasonography in dogs and cats: 488 cases (2002-2011)


Seiler, Gabriela S; Brown, James C; Reetz, Jennifer A; Taeymans, Olivier; Bucknoff, Melissa; Rossi, Federica; Ohlerth, Stefanie; Alder, Daniela; Rademacher, Nathalie; Drost, Wm Tod; Pollard, Rachel E; Travetti, Olga; Pey, Pascaline; Saunders, Jimmy H; Shanaman, Miriam M; Oliveira, Cintia R; O'Brien, Robert T; Gaschen, Lorrie (2013). Safety of contrast-enhanced ultrasonography in dogs and cats: 488 cases (2002-2011). Journal of the American Veterinary Medical Association, 242(9):1255-1259.

Abstract

OBJECTIVE: To determine the incidence of adverse events within 24 hours after contrast-enhanced ultrasonography (CEUS) in dogs and cats and compare the risk of death within 24 hours after imaging for animals that underwent ultrasonography with and without injection of a contrast agent.
DESIGN: Retrospective case-control study.
ANIMALS: 750 animals (411 case dogs, 238 control dogs, 77 case cats, and 24 control cats).
PROCEDURES: At 11 institutions, medical records were reviewed of dogs and cats that had CEUS performed (cases) as were medical records of dogs and cats with clinical signs similar to those of case animals that had ultrasonography performed without injection of a contrast agent (controls). Information regarding signalment; preexisting disease; type, dose, and administration route of contrast agent used; immediate (within 1 hour after CEUS) and delayed (> 1 and ≤ 24 hours after CEUS) adverse events; and occurrence and cause of death (when available) was extracted from each medical record. Risk of death within 24 hours after ultrasonography was compared between case and control animals.
RESULTS: Of the 411 case dogs, 3 had immediate adverse events (vomiting or syncope) and 1 had a delayed adverse event (vomiting). No adverse events were recorded for case cats. Twenty-three of 357 (6.4%) clinically ill case animals and 14 of 262 (5.3%) clinically ill control animals died within 24 hours after ultrasonography; risk of death did not differ between cases and controls.
CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that CEUS was safe in dogs and cats.

Abstract

OBJECTIVE: To determine the incidence of adverse events within 24 hours after contrast-enhanced ultrasonography (CEUS) in dogs and cats and compare the risk of death within 24 hours after imaging for animals that underwent ultrasonography with and without injection of a contrast agent.
DESIGN: Retrospective case-control study.
ANIMALS: 750 animals (411 case dogs, 238 control dogs, 77 case cats, and 24 control cats).
PROCEDURES: At 11 institutions, medical records were reviewed of dogs and cats that had CEUS performed (cases) as were medical records of dogs and cats with clinical signs similar to those of case animals that had ultrasonography performed without injection of a contrast agent (controls). Information regarding signalment; preexisting disease; type, dose, and administration route of contrast agent used; immediate (within 1 hour after CEUS) and delayed (> 1 and ≤ 24 hours after CEUS) adverse events; and occurrence and cause of death (when available) was extracted from each medical record. Risk of death within 24 hours after ultrasonography was compared between case and control animals.
RESULTS: Of the 411 case dogs, 3 had immediate adverse events (vomiting or syncope) and 1 had a delayed adverse event (vomiting). No adverse events were recorded for case cats. Twenty-three of 357 (6.4%) clinically ill case animals and 14 of 262 (5.3%) clinically ill control animals died within 24 hours after ultrasonography; risk of death did not differ between cases and controls.
CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that CEUS was safe in dogs and cats.

Citations

11 citations in Web of Science®
13 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Veterinary Clinic > Department of Small Animals
Dewey Decimal Classification:570 Life sciences; biology
Language:English
Date:2013
Deposited On:22 Jan 2014 13:19
Last Modified:05 Apr 2016 17:23
Publisher:American Veterinary Medical Association
ISSN:0003-1488
Publisher DOI:https://doi.org/10.2460/javma.242.9.1255
PubMed ID:23600783

Download

Full text not available from this repository.
View at publisher

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations